Notably, overexpression of USP7 has been detected in multiple myeloma, neuroblastoma, hepatocellular carcinoma, prostate cancer, breast cancer, and ovarian cancer, in which inhibition of USP7 suppresses proliferation and induces death of cancer cells independently of their p53 status. This evidence concerns the gene USP7 and prostate carcinoma.